ArticleJournal of hematology2024

Clinical Efficacy of Programmed Cell Death Ligand 1 Antibody in Treatment of Extranodal Natural Killer/T-Cell Lymphoma With Hemophagocytic Lymphohistiocytosis.

Chun Li Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.